Relationship Between Hematologic Inflammatory Markers and Glycemic Control in Type 2 Diabetes Mellitus Patients in a Tertiary Hospital in Nigeria

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Sep 30

PMID 39347208

Authors

Lemchukwu Amaeshi

Olufunto O Kalejaiye

Oluwarotimi B Olopade

Michael Kehinde

Affiliations

Soon will be listed here.

Abstract

Introduction: Hematologic inflammatory biomarkers derived from a full blood count (FBC) are elevated in Type 2 diabetes mellitus (DM). In low- and middle-income countries like Nigeria, a FBC is an affordable and easily available test, even in rural areas. Glycated hemoglobin (HbA1c), a measure of glycemic control, has been found to correlate with hematologic inflammatory markers. In Nigeria, where health care is expensive and patients essentially pay out of pocket, a more affordable and accessible alternative to HbA1c in determining glycemic control is needed. Therefore, this study aimed to determine the relationship between Hb A1c and hematologic inflammatory biomarkers, neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and mean platelet volume (MPV), in predicting glycemic control.

Methods: This was a six-month study of 109 patients with Type 2 DM in a tertiary hospital in Lagos. The patients' HbA1c and FBC were measured. NLR, PLR, and MPV were derived from the FBC values. We categorized the patients based on glycemic control. Spearman correlation analysis was used to determine the relationship between HbA1c and the inflammatory biomarkers.

Results: There was no significant difference in NLR, PLR, and MPV between optimal and suboptimal controlled diabetic patients. Spearman's correlation analysis showed no significant association between NLR, PLR, MPV, and HbA1c in the patients (NLR: r=0.027, P=0.680; PLR: r=-0.091, P=0.356; MPV: r=-0.032, P=0.744).

Conclusion: The inflammatory markers studied had no significant relationship with HbA1c and might not help monitor glycemic control in Type 2 DM patients.

References

Kakouros N, Rade J, Kourliouros A, Resar J . Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. Int J Endocrinol. 2011; 2011:742719. PMC: 3159301. DOI: 10.1155/2011/742719. View

Temelkova-Kurktschiev T, Siegert G, Bergmann S, Henkel E, Koehler C, Jaross W . Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism. 2002; 51(6):743-9. DOI: 10.1053/meta.2002.32804. View

Unubol M, Ayhan M, Guney E . The relationship between mean platelet volume with microalbuminuria and glycemic control in patients with type II diabetes mellitus. Platelets. 2011; 23(6):475-80. DOI: 10.3109/09537104.2011.634934. View

KINNEAR T . The pattern of diabetes mellitus in a Nigerian teaching hospital. East Afr Med J. 1963; 40:288-94. View

Dolasik I, Sener S, Celebi K, Aydin Z, Korkmaz U, Canturk Z . The effect of metformin on mean platelet volume in dıabetıc patients. Platelets. 2012; 24(2):118-21. DOI: 10.3109/09537104.2012.674165. View

. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012; 36 Suppl 1:S67-74. PMC: 3537273. DOI: 10.2337/dc13-S067. View

Isoda K, Young J, Zirlik A, MacFarlane L, Tsuboi N, Gerdes N . Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arterioscler Thromb Vasc Biol. 2005; 26(3):611-7. DOI: 10.1161/01.ATV.0000201938.78044.75. View

. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33 Suppl 1:S62-9. PMC: 2797383. DOI: 10.2337/dc10-S062. View

Budzianowski J, Pieszko K, Burchardt P, Rzezniczak J, Hiczkiewicz J . The Role of Hematological Indices in Patients with Acute Coronary Syndrome. Dis Markers. 2017; 2017:3041565. PMC: 5646322. DOI: 10.1155/2017/3041565. View

10.

Alberti K, Zimmet P . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15(7):539-53. DOI: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. View

11.

Diaz-Morales N, Rovira-Llopis S, Banuls C, Lopez-Domenech S, Escribano-Lopez I, Veses S . Does Metformin Protect Diabetic Patients from Oxidative Stress and Leukocyte-Endothelium Interactions?. Antioxid Redox Signal. 2017; 27(17):1439-1445. DOI: 10.1089/ars.2017.7122. View

12.

Lippi G, Salvagno G, Nouvenne A, Meschi T, Borghi L, Targher G . The mean platelet volume is significantly associated with higher glycated hemoglobin in a large population of unselected outpatients. Prim Care Diabetes. 2014; 9(3):226-30. DOI: 10.1016/j.pcd.2014.08.002. View

13.

Hussain M, Babar M, Akhtar L, Hussain M . Neutrophil lymphocyte ratio (NLR): A well assessment tool of glycemic control in type 2 diabetic patients. Pak J Med Sci. 2018; 33(6):1366-1370. PMC: 5768826. DOI: 10.12669/pjms.336.12900. View

14.

Hekimsoy Z, Payzin B, Ornek T, Kandogan G . Mean platelet volume in Type 2 diabetic patients. J Diabetes Complications. 2004; 18(3):173-6. DOI: 10.1016/S1056-8727(02)00282-9. View

15.

Sharpe P, Trinick T . Mean platelet volume in diabetes mellitus. Q J Med. 1993; 86(11):739-42. View

16.

Mertoglu C, Gunay M . Neutrophil-Lymphocyte ratio and Platelet-Lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus. Diabetes Metab Syndr. 2016; 11 Suppl 1:S127-S131. DOI: 10.1016/j.dsx.2016.12.021. View

17.

Ridker P, Cushman M, Stampfer M, Tracy R, Hennekens C . Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997; 336(14):973-9. DOI: 10.1056/NEJM199704033361401. View

18.

Korniluk A, Koper-Lenkiewicz O, Kaminska J, Kemona H, Dymicka-Piekarska V . Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions. Mediators Inflamm. 2019; 2019:9213074. PMC: 6501263. DOI: 10.1155/2019/9213074. View

19.

Demirtas L, Degirmenci H, Akbas E, Ozcicek A, Timuroglu A, Gurel A . Association of hematological indicies with diabetes, impaired glucose regulation and microvascular complications of diabetes. Int J Clin Exp Med. 2015; 8(7):11420-7. PMC: 4565341. View

20.

Kaushansky K . The molecular mechanisms that control thrombopoiesis. J Clin Invest. 2005; 115(12):3339-47. PMC: 1297257. DOI: 10.1172/JCI26674. View